202 related articles for article (PubMed ID: 29610559)
1. A double blind, placebo-controlled, randomized clinical trial that breast milk derived-
Shin SP; Choi YM; Kim WH; Hong SP; Park JM; Kim J; Kwon O; Lee EH; Hahm KB
J Clin Biochem Nutr; 2018 Mar; 62(2):179-186. PubMed ID: 29610559
[TBL] [Abstract][Full Text] [Related]
2. Effect of
Kim JY; Park YJ; Lee HJ; Park MY; Kwon O
Food Sci Biotechnol; 2018 Jun; 27(3):853-857. PubMed ID: 30263811
[No Abstract] [Full Text] [Related]
3. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
4. Lactobacillus gasseri BNR17 Supplementation Reduces the Visceral Fat Accumulation and Waist Circumference in Obese Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.
Kim J; Yun JM; Kim MK; Kwon O; Cho B
J Med Food; 2018 May; 21(5):454-461. PubMed ID: 29688793
[TBL] [Abstract][Full Text] [Related]
5. The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Sun YY; Li M; Li YY; Li LX; Zhai WZ; Wang P; Yang XX; Gu X; Song LJ; Li Z; Zuo XL; Li YQ
Sci Rep; 2018 Feb; 8(1):2964. PubMed ID: 29445178
[TBL] [Abstract][Full Text] [Related]
6. Effect of Lactobacillus gasseri BNR17 on Overweight and Obese Adults: A Randomized, Double-Blind Clinical Trial.
Jung SP; Lee KM; Kang JH; Yun SI; Park HO; Moon Y; Kim JY
Korean J Fam Med; 2013 Mar; 34(2):80-9. PubMed ID: 23560206
[TBL] [Abstract][Full Text] [Related]
7. The Effect of
Lee S; Jung DH; Park M; Yeon SW; Jung SH; Yun SI; Park HO; Yoo W
J Microbiol Biotechnol; 2021 Sep; 31(9):1281-1287. PubMed ID: 34319260
[TBL] [Abstract][Full Text] [Related]
8. Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice.
Kang JH; Yun SI; Park MH; Park JH; Jeong SY; Park HO
PLoS One; 2013; 8(1):e54617. PubMed ID: 23382926
[TBL] [Abstract][Full Text] [Related]
9. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.
Ishaque SM; Khosruzzaman SM; Ahmed DS; Sah MP
BMC Gastroenterol; 2018 May; 18(1):71. PubMed ID: 29801486
[TBL] [Abstract][Full Text] [Related]
10. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Yoon JS; Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Chung WS; Seo JG
J Gastroenterol Hepatol; 2014 Jan; 29(1):52-9. PubMed ID: 23829297
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life.
Choi CH; Jo SY; Park HJ; Chang SK; Byeon JS; Myung SJ
J Clin Gastroenterol; 2011 Sep; 45(8):679-83. PubMed ID: 21301358
[TBL] [Abstract][Full Text] [Related]
12. The effect of Xiang-Sha-Liu-Jun-Zi tang (XSLJZT) on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial.
Shih YS; Tsai CH; Li TC; Lai HC; Wang KT; Liao WL; Hsieh CL
J Ethnopharmacol; 2019 Jun; 238():111889. PubMed ID: 31009707
[TBL] [Abstract][Full Text] [Related]
13. The effect of a multispecies probiotic on microbiota composition in a clinical trial of patients with diarrhea-predominant irritable bowel syndrome.
Hod K; Dekel R; Aviv Cohen N; Sperber A; Ron Y; Boaz M; Berliner S; Maharshak N
Neurogastroenterol Motil; 2018 Dec; 30(12):e13456. PubMed ID: 30136337
[TBL] [Abstract][Full Text] [Related]
14. Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes.
Yun SI; Park HO; Kang JH
J Appl Microbiol; 2009 Nov; 107(5):1681-6. PubMed ID: 19457033
[TBL] [Abstract][Full Text] [Related]
15. A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
Chen C; Tao C; Liu Z; Lu M; Pan Q; Zheng L; Li Q; Song Z; Fichna J
Phytother Res; 2015 Nov; 29(11):1822-7. PubMed ID: 26400188
[TBL] [Abstract][Full Text] [Related]
16. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
[TBL] [Abstract][Full Text] [Related]
17. Effects of Lactobacillus gasseri BNR17 on body weight and adipose tissue mass in diet-induced overweight rats.
Kang JH; Yun SI; Park HO
J Microbiol; 2010 Oct; 48(5):712-4. PubMed ID: 21046354
[TBL] [Abstract][Full Text] [Related]
18. Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrome patients: a randomized double-blind clinical trial.
Abbasnezhad A; Amani R; Hajiani E; Alavinejad P; Cheraghian B; Ghadiri A
Neurogastroenterol Motil; 2016 Oct; 28(10):1533-44. PubMed ID: 27154424
[TBL] [Abstract][Full Text] [Related]
19. Effects of Synbiotic Preparation Containing
Lee HJ; Cho JH; Cho WJ; Gang SH; Park SH; Jung BJ; Kim HB; Song KH
Animals (Basel); 2022 Mar; 12(5):. PubMed ID: 35268209
[TBL] [Abstract][Full Text] [Related]
20. Effect of administering a multi-species probiotic mixture on the changes in fecal microbiota and symptoms of irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Yoon H; Park YS; Lee DH; Seo JG; Shin CM; Kim N
J Clin Biochem Nutr; 2015 Sep; 57(2):129-34. PubMed ID: 26388670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
